Black Swan Pharmaceuticals
Wake Forest, US · Founded 2018 · Delaware corporation
Find your way into Black Swan Pharmaceuticals
Sign up to see every warm intro you have to Black Swan Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Black Swan Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JA
Julian ArbuckleNamed on SEC filing
CM
Craig MetzNamed on SEC filing
AA
Anthony AkkariNamed on SEC filing
SA
Steve ArnottNamed on SEC filing
OD
Om DhingraNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2M disclosed across 2 rounds · 2020–2021
▶$1.9MraisedSep 2021 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.9MraisedSep 2021 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Om DhingraDirector
- Anthony AkkariDirector
- Steve ArnottDirector
- Julian ArbuckleDirector
- Craig MetzExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$130.2KraisedApr 2020 · 1 investors · PharmaceuticalsRule 506(b)
▶$130.2KraisedApr 2020 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Julian ArbuckleDirector
- Craig MetzExecutive Officer, Director
- Anthony AkkariDirector
- Steve ArnottDirector
- Om DhingraDirector
- Offering amount
- $600K
- Amount sold
- $130.2K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Black Swan Pharmaceuticals raised?
- Black Swan Pharmaceuticals has disclosed $2M raised across 2 rounds.
- Where is Black Swan Pharmaceuticals headquartered?
- Black Swan Pharmaceuticals is headquartered in Wake Forest, US.